A kind of cellulose ether and preparation method thereof

Through the modification treatment and polymerization of CMC, cellulose ethers with excellent antibacterial, antiviral and drug-resistant properties are generated, which solves the problem of insufficient performance of existing cellulose ethers in the pharmaceutical field and expands its high-salt environment scope of application under.

CN118290656BActive Publication Date: 2024-11-01吴桥县齐源纤维素有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410492788.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-04-23
Publication Date
2024-11-01
Estimated Expiration
2044-04-23

AI Technical Summary

Technical Problem

The application of existing cellulose ethers in the pharmaceutical field is limited by their insufficient antibacterial, antiviral and drug resistance, and their poor performance in high-salt environments.

Method used

By modifying carboxymethylcellulose (CMC), including selective oxidation to form bisaldehyde CMC, and reacting with L-penicillamine and piperidine bromide, it forms a modified CMC with Schiff base structure , and then polymerize with substances such as cinnamide and pyridine bromide to form cellulose ethers with hydrophobic and antibacterial properties.

Benefits of technology

Expand the application scope of cellulose ether in the pharmaceutical field, imparting excellent anti-salt, renewable, biodegradable, antiviral, antibacterial and drug-resistant properties, and enhancing its stability and biological activity in high-salt environments .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004805913420000021
    Figure BDA0004805913420000021
  • Figure BDA0004805913420000022
    Figure BDA0004805913420000022
  • Figure BDA0004805913420000031
    Figure BDA0004805913420000031
Patent Text Reader

Abstract

The invention discloses a cellulose ether, comprising the following raw materials in parts by weight: 1-3 parts of modified CMC, 3-8 parts of cinnamamide and 0.25-0.5 parts of piperidine bromide. The preparation process is as follows: CMC (carboxymethyl cellulose) is first selectively oxidized to generate dialdehyde CMC, and then dialdehyde CMC is subjected to Schiff base reaction with the secondary amine group of L-penicillamine to obtain modified CMC. Then, piperidine methacrylate ethanol ester is first reacted with 1-bromooctane to obtain piperidine bromide, and then piperidine bromide, cinnamamide and modified CMC are copolymerized under the initiation of potassium persulfate to obtain cellulose ether. The preparation method has the advantages of easy availability of raw materials, simple method and low cost. The obtained cellulose ether is an amphiphilic hydrophobic water-soluble copolymer with biological activities such as antiviral and antibacterial properties, and has excellent application prospects in the field of medicine.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of polymer material preparation, and in particular to cellulose ether and a preparation method thereof. Background Art

[0002] Cellulose is a polyhydroxy polymer compound that is neither soluble nor meltable. After etherification, cellulose can be dissolved in water, dilute alkaline solutions and organic solvents, and has thermoplasticity. According to the chemical structure of the substituents, it can be divided into anionic, cationic and non-ionic ethers. Each glucose ring in the cellulose macromolecule contains three hydroxyl groups, the primary hydroxyl group on the sixth carbon atom and the secondary hydroxyl groups on the second and third carbon atoms. The hydrogen in the hydroxyl group is replaced by a hydrocarbon group to form a cellulose ether derivative. Water-soluble cellulose ether CMC (carboxymethyl cellulose) is often used in the medical field such as drug coating materials, sustained-release additives for pharmaceuticals, and thickeners and emulsion stabilizers for liquid pharmaceuticals. CMC can also be used as an emulsifier and thickener in yogurt, dairy products and toothpaste. Previously, researchers have prepared berberine-modified CMC, which has the good antibacterial properties of berberine, and has the characteristics of CMC such as salt resistance, renewability and biodegradability.

[0003] In recent years, the unique salt-resistant viscosity-increasing performance and amphiphilicity of hydrophobically modified polymers in aqueous solution have become one of the research hotspots. A study used CMC, acrylamide and N, N-dimethyloctyl (2-methacryloyloxyethyl) ammonium bromide as raw materials, and under the action of an initiator, a multifunctional hydrophobic water-soluble amphoteric cellulose graft copolymer with hydrophilicity, lipophilicity and salt-resistant viscosity-increasing was prepared.

[0004] Therefore, graft copolymers based on the cellulose main chain can be prepared by the graft polymerization method. Such copolymers fully combine the advantages of cellulose itself and the characteristics of other polymers, giving cellulose specific properties, which is a promising research direction. Summary of the invention

[0005] In order to solve the above problems, the present invention provides a cellulose ether and a preparation method thereof.

[0006] The purpose of the present invention can be achieved by the following technical solutions:

[0007] Add modified CMC to 15-20mL deionized water, add 4-5mL acetonitrile, start magnetic stirring, pass nitrogen, and heat the water bath to 40℃. After 25-30min, add potassium persulfate, and after 10-15min, add cinnamamide and piperidine bromide in sequence. React in a water bath at 80℃ for 5-6h under magnetic stirring, extract and separate with ethanol, purify, and vacuum dry at 80℃ to obtain cellulose ether. The structure of cellulose ether is shown below:

[0008]

[0009] Furthermore, the modified CMC is prepared by the following steps:

[0010] Step A1: CMC is added to deionized water, and magnetically stirred for 12 hours at 35° C. and 1500 r / min, and then sodium periodate solution is added, and the pH value is adjusted to 3.0 with sulfuric acid solution, and stirring is continued for 4 hours under light-proof conditions. The product is precipitated with anhydrous ethanol, washed, and dried to obtain dialdehyde CMC. The dosage ratio of CMC, deionized water, sodium periodate solution, and sulfuric acid solution is 1.0 g: 20 mL: 10-12 mL: 40-45 mL;

[0011] In step A1, CMC reacts with sodium periodate, and the second and third hydroxyl groups in the CMC structure are selectively oxidized by sodium periodate to generate dialdehyde CMC. The structure of dialdehyde CMC is shown below:

[0012]

[0013] Step A2: adding dialdehyde CMC and L-penicillamine into deionized water, adjusting the pH value to 5-6 at 40-50° C., magnetically stirring at 1500 r / min for 12 h, filtering and drying to obtain modified CMC, wherein the amount ratio of dialdehyde CMC, L-penicillamine and deionized water is 0.01 mol: 0.02 mol: 20 mL;

[0014] In step A2, dialdehyde CMC reacts with L-penicillamine, and the aldehyde group and the amino group react with a Schiff base to generate a modified CMC in which CMC and L-penicillamine are grafted via a Schiff base structure; CMC has excellent salt resistance, renewability and biodegradability, and L-penicillamine contains a thiol group and an amino acid structure, and has good biocompatibility. L-penicillamine and CMC are connected via a Schiff base structure, and on the basis of giving CMC antiviral ability, it has the antibacterial property of Schiff base. The structure of the modified CMC is shown below:

[0015]

[0016] Further, the piperidine bromide is prepared by the following steps:

[0017] Under nitrogen protection, piperidine methacrylate ethanol and 1-bromoalkane are added to acetone, stirred and mixed, and then a sodium hydroxide solution is added. The mixture is stirred and refluxed at 40-50° C. for 9 hours, and then the mixture is soaked and extracted with anhydrous ether for 5 times, and dried to obtain piperidine bromide. The amount ratio of piperidine methacrylate ethanol, 1-bromoalkane, acetone and sodium hydroxide solution is 0.1 mol: 0.15-0.18 mol: 120 mL: 8-10 mL, 1-bromoalkane is one of 1-bromooctane, 1-bromododecane and 1-bromohexadecane, and the molar concentration of the sodium hydroxide solution is 0.1 mol / L.

[0018] During the reaction, piperidine ethanol methacrylate reacts with 1-bromoalkane to generate piperidine bromide containing long-chain alkyl groups; the long-chain alkyl group is hydrophobic and enhances oil solubility; the piperidine ring is an important pharmacophore and dominant skeleton, with antibacterial, anti-inflammatory and antiviral biological activities. Like many nitrogen-containing groups, the piperidine ring can form additional interactions with the target, easily pass through the cell membrane, and solve the problem of drug resistance. The structure of piperidine bromide is shown below:

[0019]

[0020] The beneficial effects of the present invention are as follows: dialdehyde carboxymethyl cellulose is obtained by selectively oxidizing the di- and tri-hydroxyl groups of CMC, and the dialdehyde cellulose undergoes a Schiff base reaction with the secondary amine in L-penicillamine to obtain a modified CMC having a Schiff base structure and an L-penicillamine structure. CMC has excellent salt resistance, renewability and biodegradability. L-penicillamine contains sulfhydryl and amino acid structures and has good biocompatibility. Schiff base has good antibacterial and antiviral biological activities. L-penicillamine is connected to CMC through the Schiff base structure, which gives CMC the antibacterial property of Schiff base on the basis of giving it antiviral ability, thereby expanding the application scope of CMC in the medical field.

[0021] Methacrylate piperidine ethanol ester and 1-bromooctane undergo quaternization reaction to generate a pyridine bromide intermediate with cations and hydrophobic long-chain alkyl groups. Modified CMC, cinnamamide and pyridine bromide intermediate react with potassium persulfate as initiator to generate cellulose ether, which is a new hydrophobic water-soluble graft copolymer material. Cinnamamide has an insect repellent effect, the phenylpropenyl structure has strong chemical stability, and the amide structure can be hydrated, which makes the cellulose ether more water-soluble, structurally stable and has a chemical insect repellent effect. The piperidine ring in the pyridine bromide intermediate is an important pharmacophore and dominant skeleton, with antibacterial, anti-inflammatory and antiviral biological activities. Like many nitrogen-containing groups, the piperidine ring can form additional interactions with the target, easily pass through the cell membrane, solve the problem of drug resistance, and give cellulose ether drug resistance. The long-chain alkyl in piperidine bromide is highly hydrophobic, which increases the oil solubility of cellulose ether. The hydrophilic and lipophilic cellulose ether synthesized by the invention has biological activities such as antiviral, antibacterial, chemical insect repellent and drug resistance, enriches the use of cellulose in medicine and guides the diversification of drug research directions. DETAILED DESCRIPTION

[0022] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0023] Example 1

[0024] A modified CMC is prepared by the following steps:

[0025] Step A1: CMC is added to deionized water, and magnetically stirred for 12 hours at 35°C and 1500 r / min, and then sodium periodate solution is added, and the pH value is adjusted to 3.0 with sulfuric acid solution, and stirring is continued for 4 hours under light-proof conditions. The product is precipitated with anhydrous ethanol, washed, and dried to obtain dialdehyde CMC. The amount ratio of CMC, deionized water, sodium periodate solution and sulfuric acid solution is 1.0 g: 20 mL: 10 mL: 40 mL;

[0026] Step A2: Add dialdehyde CMC and L-penicillamine into deionized water, adjust the pH value to 5 at 40°C, stir magnetically at 1500 r / min for 12 h, filter and dry to obtain modified CMC, the dosage ratio of dialdehyde CMC, L-penicillamine and deionized water is 0.01 mol: 0.02 mol: 20 mL.

[0027] Example 2

[0028] A modified CMC is prepared by the following steps:

[0029] Step A1: CMC is added to deionized water, and magnetically stirred for 12 hours at 35°C and 1500 r / min, and then sodium periodate solution is added, and the pH value is adjusted to 3.0 with sulfuric acid solution, and stirring is continued for 4 hours under light-proof conditions. The product is precipitated with anhydrous ethanol, washed, and dried to obtain dialdehyde CMC. The amount ratio of CMC, deionized water, sodium periodate solution and sulfuric acid solution is 1.0 g: 20 mL: 11 mL: 42 mL;

[0030] Step A2: Add dialdehyde CMC and L-penicillamine into deionized water, adjust the pH value to 5.5 at 45°C, stir magnetically at 1500 r / min for 12 h, filter and dry to obtain modified CMC, the dosage ratio of dialdehyde CMC, L-penicillamine and deionized water is 0.01 mol: 0.02 mol: 20 mL.

[0031] Example 3

[0032] A modified CMC is prepared by the following steps:

[0033] Step A1: CMC is added to deionized water, and magnetically stirred for 12 hours at 35° C. and 1500 r / min, and then sodium periodate solution is added, and the pH value is adjusted to 3.0 with sulfuric acid solution, and stirring is continued for 4 hours under light-proof conditions. The product is precipitated with anhydrous ethanol, washed, and dried to obtain dialdehyde CMC. The amount ratio of CMC, deionized water, sodium periodate solution, and sulfuric acid solution is 1.0 g: 20 mL: 12 mL: 45 mL;

[0034] Step A2: Add dialdehyde CMC and L-penicillamine into deionized water, adjust the pH value to 6 at 50°C, stir magnetically at 1500 r / min for 12 h, filter and dry to obtain modified CMC, the dosage ratio of dialdehyde CMC, L-penicillamine and deionized water is 0.01 mol: 0.02 mol: 20 mL.

[0035] Example 4

[0036] A piperidine bromide is prepared by the following steps:

[0037] Under nitrogen protection, piperidine methacrylate ethanol and 1-bromoalkane are added to acetone, stirred and mixed, and then sodium hydroxide solution is added. The mixture is stirred and refluxed at 40°C for 9 hours, and then the mixture is extracted by immersion in anhydrous ether for 5 times and dried to obtain piperidine bromide. The amount ratio of piperidine methacrylate ethanol, 1-bromoalkane, acetone and sodium hydroxide solution is 0.1 mol: 0.15 mol: 120 mL: 8 mL, 1-bromoalkane is 1-bromooctane, and the molar concentration of the sodium hydroxide solution is 0.1 mol / L.

[0038] Example 5

[0039] A piperidine bromide is prepared by the following steps:

[0040] Under nitrogen protection, piperidine methacrylate ethanol and 1-bromoalkane are added to acetone, stirred and mixed, and then sodium hydroxide solution is added. The mixture is stirred and refluxed at 45°C for 9 hours, and then the mixture is extracted by immersion in anhydrous ether for 5 times and dried to obtain piperidine bromide. The amount ratio of piperidine methacrylate ethanol, 1-bromoalkane, acetone and sodium hydroxide solution is 0.1 mol: 0.16 mol: 120 mL: 9 mL, 1-bromoalkane is 1-bromododecane, and the molar concentration of the sodium hydroxide solution is 0.1 mol / L.

[0041] Example 6

[0042] A piperidine bromide is prepared by the following steps:

[0043] Under nitrogen protection, piperidine methacrylate ethanol and 1-bromoalkane are added to acetone, stirred and mixed, and then sodium hydroxide solution is added. The mixture is stirred and refluxed at 50°C for 9 hours, and then the mixture is extracted with anhydrous ether for 5 times and dried to obtain piperidine bromide. The amount ratio of piperidine methacrylate ethanol, 1-bromoalkane, acetone and sodium hydroxide solution is 0.1 mol: 0.18 mol: 120 mL: 10 mL, 1-bromoalkane is 1-bromohexadecane, and the molar concentration of the sodium hydroxide solution is 0.1 mol / L.

[0044] Example 7

[0045] A cellulose ether, characterized by comprising the following raw materials in parts by weight: 1 part of modified CMC, 3 parts of cinnamamide and 0.25 parts of piperidinium bromide.

[0046] The cellulose ether is prepared by the following steps:

[0047] The modified CMC obtained in Example 1 was added to 15 mL of deionized water, and 4 mL of acetonitrile was added, magnetic stirring was started, nitrogen was passed, and the water bath was heated to 40°C. After 25 mL, potassium persulfate was added, and cinnamamide and piperidine bromide obtained in Example 4 were added in sequence after 10 minutes, and the reaction was carried out in a water bath at 80°C for 5 hours under magnetic stirring, and ethanol was used for extraction, separation, purification, and vacuum drying at 80°C to obtain cellulose ether.

[0048] Example 8

[0049] A cellulose ether, characterized by comprising the following raw materials in parts by weight: 2 parts of modified CMC, 5 parts of cinnamamide and 0.35 parts of piperidinium bromide.

[0050] The cellulose ether is prepared by the following steps:

[0051] The modified CMC obtained in Example 2 was added to 17 mL of deionized water, and 4.5 mL of acetonitrile was added, magnetic stirring was started, nitrogen was passed, and the water bath was heated to 40° C. After 27 minutes, potassium persulfate was added, and after 12 minutes, cinnamamide and piperidine bromide obtained in Example 5 were added in sequence, and the reaction was carried out in a water bath at 80° C. under magnetic stirring for 5.5 hours, and ethanol was used for extraction, separation, purification, and vacuum drying at 80° C. to obtain cellulose ether.

[0052] Example 9

[0053] A cellulose ether, characterized by comprising the following raw materials in parts by weight: 3 parts of modified CMC, 8 parts of cinnamamide and 0.5 parts of piperidinium bromide.

[0054] The cellulose ether is prepared by the following steps:

[0055] The modified CMC obtained in Example 3 was added to 20 mL of deionized water, and 5 mL of acetonitrile was added, magnetic stirring was started, nitrogen was passed, and the water bath was heated to 40° C. Potassium persulfate was added after 30 minutes, and cinnamamide and piperidine bromide obtained in Example 6 were added in sequence after 15 minutes, and the mixture was reacted in a water bath at 80° C. for 6 hours under magnetic stirring, and extracted and separated with ethanol, purified, and vacuum dried at 80° C. to obtain cellulose ether.

[0056] Comparative Example 1

[0057] This comparative example is commercially available CMC.

[0058] Comparative Example 2

[0059] Compared with Example 9, the modified CMC was replaced by CMC, and the other steps were the same as in Example 9 to obtain cellulose ether.

[0060] Comparative Example 3

[0061] Compared with Example 9, the raw material piperidine ethanol methacrylate used in Example 6 was replaced with 2-(dimethylamino)ethyl methacrylate, and the other steps were exactly the same as in Example 9 to obtain cellulose ether.

[0062] The cellulose ether prepared by the present invention is further tested for its effect, and the test results are as follows.

[0063] In order to test the cellulose ether prepared in the present invention, the antibacterial property was determined according to GB / T 20944 "Evaluation of antibacterial properties of textiles", and the antiviral activity was determined according to ISO 18184 "Determination of antiviral activity of textile products", and the results are shown in Tables 1 and 2.

[0064] Table 1:

[0065]

[0066]

[0067] Table 2:

[0068]

[0069] According to the data in Table 1 and Table 2, compared with Comparative Example 1, Examples 7, 8 and 9 show that the cellulose ether prepared by the present invention has excellent antibacterial and antiviral properties compared with commercially available cellulose ethers; compared with Comparative Example 2, Example 9 shows that compared with CMC, the cellulose ether synthesized without using modified CMC, that is, without introducing Schiff base structure and L-penicillamine structure, but only having piperidine structure, has much weakened antibacterial and antiviral properties of cellulose ether; compared with Comparative Example 3, Example 9 shows that without introducing piperidine structure, but only having Schiff base structure and L-penicillamine structure, has slightly weakened antiviral and antibacterial properties of cellulose ether.

[0070] The above contents are merely examples and explanations of the concept of the present invention. The technicians in this technical field may make various modifications or additions to the specific embodiments described or replace them in a similar manner. As long as they do not deviate from the concept of the invention or exceed the scope defined by the claims, they should all fall within the protection scope of the present invention.

Claims

1. A cellulose ether, characterized in that: The method comprises the following raw materials in parts by weight: 1-3 parts of modified CMC, 3-8 parts of cinnamamide and 0.25-0.5 parts of piperidine bromide; The modified CMC is prepared by the following steps: Step A1: CMC is added to deionized water, and magnetically stirred at 35°C and 1500 r / min for 12 hours, and then sodium periodate solution is added, and the pH value is adjusted to 3.0 with sulfuric acid solution, and stirring is continued for 4 hours under light-proof conditions. The product is precipitated with anhydrous ethanol, washed, and dried to obtain dialdehyde CMC; Step A2: adding dialdehyde CMC and L-penicillamine to deionized water, adjusting the pH value to 5-6 at 40-50° C., magnetically stirring at 1500 r / min for 12 h, filtering and drying to obtain modified CMC; The piperidine bromide is prepared by the following steps: Under nitrogen protection, piperidine methylacrylate ethanol ester and 1-bromoalkane are added to acetone, stirred and mixed, and then sodium hydroxide solution is added. The mixture is stirred and refluxed at 40-50°C for 9 hours, and then extracted with anhydrous ether for 5 times and dried to obtain piperidine bromide.

2. A cellulose ether according to claim 1, characterized in that: The dosage ratio of CMC, deionized water, sodium periodate solution and sulfuric acid solution in step A1 is 1.0 g: 20 mL: 10-12 mL: 40-45 mL.

3. A cellulose ether according to claim 1, characterized in that: The mass concentration of sodium periodate solution is 0.1 g / mL, and the molar concentration of sulfuric acid solution is 1 mol / L.

4. The cellulose ether according to claim 1, characterized in that: The usage ratio of dialdehyde CMC, L-penicillamine and deionized water in step A2 is 0.01 mol: 0.02 mol: 20 mL.

5. The cellulose ether according to claim 1, characterized in that: The usage ratio of piperidine ethanol methacrylate, 1-bromoalkane, acetone and sodium hydroxide solution is 0.1 mol: 0.15-0.18 mol: 120 mL: 8-10 mL.

6. The cellulose ether according to claim 1, characterized in that: The 1-bromoalkane is one of 1-bromooctane, 1-bromododecane and 1-bromohexadecane, and the molar concentration of the sodium hydroxide solution is 0.1 mol / L.

7. The cellulose ether according to claim 1, characterized in that: The cellulose ether is prepared by the following steps: Add modified CMC into 15-20 mL of deionized water, add 4-5 mL of acetonitrile, start magnetic stirring, pass nitrogen, heat the water bath to 40°C, add potassium persulfate after 25-30 minutes, add cinnamamide and piperidine bromide in sequence after 10-15 minutes, react in a water bath at 80°C under magnetic stirring for 5-6 hours, extract and separate with ethanol, purify, and vacuum dry at 80°C to obtain cellulose ether.